20
Participants
Start Date
June 18, 2007
Primary Completion Date
January 31, 2034
Study Completion Date
January 31, 2034
RECRUITING
Investigational Site Number : 056001, Ghent
RECRUITING
Investigational Site Number : 1910001, Zagreb
RECRUITING
Investigational Site Number : 1910002, Zagreb
RECRUITING
New York University School Of Medicine- Site Number : 840040, New York
RECRUITING
Mt. Sinai School of Medicine- Site Number : 840005, New York
RECRUITING
Investigational Site Number : 2030001, Prague
RECRUITING
Investigational Site Number : 380004, Genova
RECRUITING
Investigational Site Number : 380007, Milan
RECRUITING
O&O Alpan, LLC- Site Number : 840025, Fairfax
RECRUITING
Investigational Site Number : 380008, Brescia
RECRUITING
Investigational Site Number : 380003, Pavia
RECRUITING
Duke University Medical Center Genetics Dept- Site Number : 840037, Durham
RECRUITING
Emory University School Of Medicine- Site Number : 840060, Atlanta
RECRUITING
Investigational Site Number : 380002, Padua
RECRUITING
Investigational Site Number : 380011, Padua
RECRUITING
LSD Data Registry Site LLC- Site Number : 840094, Dublin
RECRUITING
Indianapolis University School of Medicine- Site Number : 840027, Indianapolis
RECRUITING
Spectrum for Health- Site Number : 840019, Grand Rapids
RECRUITING
Investigational Site Number : 380005, Florence
RECRUITING
Barrow Neurol Group- Site Number : 840087, Phoenix
COMPLETED
Oregon Health and Science University- Site Number : 840095, Portland
RECRUITING
Investigational Site Number : 380013, Messina
RECRUITING
Investigational Site Number : 380006, Cagliari
RECRUITING
Investigational Site Number : 380009, Monza
RECRUITING
Investigational Site Number : 380012, Roma
RECRUITING
Investigational Site Number : 380015, Roma
Genzyme, a Sanofi Company
INDUSTRY